Greetings of the Day !
Mom has completed her 6 cycles of VRD (Velcade 2 mg, Revlimid 25 mg, and dex 40 mg weekly) chemo regimen and we have got her test done.
The reports are
Immunofixation Electrophoresis
Beta-2-microglobulin,serum by CLIA: 6329.00
Serum Total Proteins 5.91 g/dL
Serum Albumin 3.69 g/dL
Alpha 1 Globulin 0.26 g/dL
Alpha 2 Globulin 0.85 g/dL
Beta 1 Globulin 0.36 g/dL
Beta 2 Globulin 0.34 g/dL
Gamma Globulin 0.41 g/dL
Album/Globulin Ratio 1.67
"M" Band Absent
IgA level, serum by Nephelometry 128.00 mg/dL
IgG level, serum by Nephelometry 589.00 mg/dL
gM, serum by Nephelometry 25.80 mg/dL
Free kappa (light chain),serum by nephelometry 22.10 mg/L
Free lambda(light chain),serum by nephelometry 16.40 mg/L
Free kappa/ lambda ratio 1.35
Immunofixation (Qualitative)
Electrophoretic Zone
IgG Absent
IgM Absent
IgA Absent
Kappa Absent
Lambda Absent
M -Band Absent
Impression: No monoclonal gammopathy seen.
Flow Cytometry Report
Multiple Myeloma Panel
Marker Result Units
B-cell Markers
CD19 22.4 % of Gated Leukocytes
Cy.Kappa 22.5 % of Gated Leukocytes
Cy.Lambda 12.8 % of Gated Leukocytes
Others
CD38 100 % of Gated Leukocytes
CD56 2.5 % of Gated Leukocytes
CD138 8.6 % of Gated Leukocytes
CD45 50.2 % of Gated Leukocytes
CD20 1.5 % of Gated Leukocytes
Interpretation of Observations
Specimen Type: - Bone Marrow showed TLC - 12,800 cells/µl.
SSC Vs CD38 Gating.
Flow cytometric analysis shows 0.4% polyclonal plasma cells expressing CD19, CD38, CD45, polyclonal for Cy.Kappa/ Cy.Lambda and rest of the markers are negative.
Impression
No evidence of multiple myeloma in the sample analysed.
Her bone marrow aspiration and biopsy show no traces of multiple myeloma and the BM is in morphological remission.
We had consulted the oncologist yesterday to discuss the further course of treatment. He has suggested us 3 options and told us to consult other doctors to make the decision.
- Stem Cell Transplant and with Maintenance Treatment - Injection of Velcade every 15 days with oral lenalidomide (Revlimid) (even if we do SCT, we need to continue with maintenance).
- Stem Cell Collection and Stem Cell Transplant at a later date - Waiting for newer treatment options, continue with maintenance treatment with injection of Velcade every 15 days with oral thalidomide.
- Only maintenance treatment with injection of Velcade every 15 days with oral thalidomide.
He was having some reservations towards stem cell transplant as mom is having del13q14.3 in her FISH test, which he says would not respond well to SCT (again, only past studies to support the claim).
Now we are in a situation wherein we need to take a decision on the next line of treatment.
My questions would be:
- What should be the next line of treatment - SCT / stem cell collection / just keep her on maintenance?
- Advantages of going ahead with stem cell transplant (will it prolong her life / better quality of living)?
- Why is that even after stem cell transplant, we need to keep her on maintenance medicines?
- Why is that she is having a low hemoglobin count (peripheral smear examination says she is having normocytic normochromic anemia)?
- Usually without a SCT how long does it take for the disease to relapse?
- Any test to be done regularly or markers to keep in mind to lookout of the disease coming back or aggravating?
- How much time do we have in hand to take the decision. Any meds to be taken during this course of wait?
- Are the meds suggested right to keep her on maintenance with SCT or no SCT?
I would like suggestions from experienced members. Really tough to take the decision.
